Dolinnov is a french preclinical research company dedicated to advancing solutions for chronic pain management, driven by a passion for science and innovation. Our mission is to improve patients’ lives by delivering cutting-edge solutions for severe and unbearable conditions.
Leveraging our proprietary conjugated L-ASO technology, we design targeted, effective, and safer therapies. This breakthrough approach directly addresses the root causes of pain through precise molecular interventions, providing hope to those enduring chemotherapy-induced pain and other challenging conditions.
Company Details
- Employees
- 2
- Founded
- -
- Address
- 418, Rue Du Mas De Verchant, Montpellier,occitanie 34170,france
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://wwww.dolinnov.com
- Keywords
- Biotechnology, Pain Management, ASO Therapy, CIPN.
- HQ
- Montpellier, Occitanie
Dolinnov Questions
Dolinnov's website is http://wwww.dolinnov.com
Dolinnov's LinkedIn profile is https://fr.linkedin.com/company/dolinnov
Dolinnov has
2 employees.
View email and phone details for 2
employees at Dolinnov.
Dolinnov's industry is
Biotechnology Research
Dolinnov's top competitors are
Kanopymed,
Insilibio,
Lineup Ocean,
Medincell,
Carbozym,
Ai-Stroke,
Hemarina,
Blue Bees Therapeutics,
Caresquad,
Clicnwork..
Dolinnov's categories are Biotechnology Research
Dolinnov's founding year is 2024
